Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Leuk Res ; 34(11): 1459-71, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20430443

ABSTRACT

Chronic myeloid leukemia (CML) management varies across Asia due to disparities in affluence and healthcare provision. We surveyed CML management practice at 33 hospitals in 14 countries/regions to identify treatment challenges and opportunities for harmonization. Patients were generally treated according to international guidelines; however, tyrosine kinase inhibitors (TKIs) and molecular monitoring are inaccessible to many patients not covered by national insurance or eligible for subsidized treatment. Late diagnosis and suboptimal monitoring, often due to cost and accessibility issues, are challenges. Priorities for Asia include: extending accessibility to TKIs; specialist laboratory monitoring; and enriching data to support regional CML management guidelines.


Subject(s)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy , Asia , Data Collection , Delayed Diagnosis , Drug Delivery Systems , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/economics , Pacific Islands , Patient Care Management/economics , Protein Kinase Inhibitors/therapeutic use , Protein-Tyrosine Kinases/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...